Autonomous University of Barcelona

Medical research

D-galactose affects aging male and female brains differently

A study coordinated by the UAB and in collaboration with the ULL reveals the biological relevance of sex in the alteration of behaviour and the neuro-immuno-endocrine system, caused by accelerated aging with a chronic treatment ...

Neuroscience

New study of the memory through optogenetics

Raül Andero Galí, one of the heads of the "Neurobiology of Stress and Addiction" research group at the Institut de Neurociències (INc) of the Universitat Autònoma de Barcelona (UAB) and researcher at Harvard University, ...

Alzheimer's disease & dementia

Loss of memory in Alzheimer's mice models reversed through gene therapy

Alzheimer's disease is the leading cause of dementia and affects some 400,000 people in Spain alone. However, no effective cure has yet been found. One of the reasons for this is the lack of knowledge about the cellular mechanisms ...

Medical research

A step towards a type 1 diabetes vaccine by using nanotherapy

For the first time, liposomes that imitate cells in the process of natural death have been used to treat diabetes. Researchers at Germans Trias Research Institute (at UAB-Campus of International Excellence Sphere) generated ...

Psychology & Psychiatry

Resilient people more satisfied with life

A study conducted by researchers at Universitat Autonoma de Barcelona reveals that individuals with a larger capacity to overcome adversities, those more resilient, are also the ones most satisfied with life. The research ...

Alzheimer's disease & dementia

Geometric study of brain cells could change strategies on Alzheimer's

Applying mathematical models used for studying the galaxies or interactions between elementary particles, researchers at the Institute of Neuroscience of the Universitat Autònoma de Barcelona, in collaboration with Massachusetts ...

Immunology

Mycobacterium in olive oil for cancer treatment

Researchers at the Universitat Autònoma de Barcelona announced one year ago that the cells of the Mycobacterium brumae offer an improved alternative to current bladder cancer treatments such as BCG, an immunotherapy based ...

page 2 from 6